Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion type Assertion NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_head.
- NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion description "[Multidrug resistance (MDR), usually mediated by overexpression of efflux transporters such as P-gp, ABCG2 and/or MRP1, remains a major obstacle hindering successful cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_provenance.
- NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion evidence source_evidence_literature NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_provenance.
- NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion SIO_000772 24032744 NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_provenance.
- NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion wasDerivedFrom befree-20150227 NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_provenance.
- NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_assertion wasGeneratedBy ECO_0000203 NP569442.RAQIpx-1Ky48Hg1GrJD2OvyH8kqSthKUcejQBln6yFdeQ130_provenance.